Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma
- 1 February 1991
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 9 (1) , 69-72
- https://doi.org/10.1007/bf00194548
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancer.1987
- FETAL HEMOGLOBIN GENE ACTIVATION IN A PHASE-II STUDY OF 5,6-DIHYDRO-5-AZACYTIDINE FOR BRONCHOGENIC-CARCINOMA1987
- A PHASE-I AND PHARMACOKINETIC STUDY OF DIHYDRO-5-AZACYTIDINE (NSC 264880)1985
- Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.Thorax, 1984
- Malignant mesothelioma 1982: Review of 4710 published casesRespiratory Medicine, 1983
- Malignant mesothelioma 1982: review of 4710 published cases.1983
- Diffuse Malignant MesotheliomaAnnals of Internal Medicine, 1982
- Synthesis and antitumor activity of dihydro-5-azacytidine, a hydrolytically stable analog of 5-azacytidineJournal of Medicinal Chemistry, 1977